CDNA
Get informed when a big investor buys or sells
+ FollowOvervalued by 103.8% based on the discounted cash flow analysis.
| Market cap | $2.42 Billion |
|---|---|
| Enterprise Value | $2.06 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.4 |
| Beta | 2.43 |
| Outstanding Shares | 51,469,375 |
| P/E Ratio | 21.7 |
|---|---|
| PEG | -1.56 |
| Price to Sales | 5.92 |
| Price to Book Ratio | 5.92 |
| Enterprise Value to Revenue | 4.49 |
| Enterprise Value to EBIT | 18.51 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 29.59%▼ 73.16% |
|---|---|
| Total Invested | $429.58M▼ 52.90% |
| Investors Holding | 71▼ 119.00% |
No data